News & Updates

APOLLO: SC daratumumab an effective, convenient option in R/R MM

16 Dec 2020 by

Subcutaneous (SC) daratumumab in combination with pomalidomide and dexamethasone (Pd) improves progression-free survival (PFS) and achieves deeper responses vs Pd alone in patients with relapsed/refractory multiple myeloma (R/R MM), results of the phase III APOLLO trial have shown.

APOLLO: SC daratumumab an effective, convenient option in R/R MM

16 Dec 2020

Dairy may be protective against colorectal cancer

16 Dec 2020

Consuming high amounts of dairy may be beneficial, leading to a lower incidence of colorectal cancer and related mortality, according to a study.

Dairy may be protective against colorectal cancer

16 Dec 2020

Adjuvant radiotherapy not recommended after radical prostatectomy

15 Dec 2020 by

In men with prostate cancer who underwent radical prostatectomy (RP), adjuvant radiotherapy (RT) showed no benefit in terms of PSA* biochemical progression and increases the risk of urinary morbidity compared with salvage RT, the RADICALS**-RT trial suggests.

Adjuvant radiotherapy not recommended after radical prostatectomy

15 Dec 2020

Niraparib improves PFS in Chinese patients with ovarian cancer

15 Dec 2020 by

An individualized dosing regimen of niraparib, a potent inhibitor of PARP 1/2, resulted in significantly improved progression-free survival (PFS) among Chinese patients with platinum-sensitive recurrent (PSR) ovarian cancer, according to a subgroup analysis of the NORA* study presented at ESMO Asia 2020.

Niraparib improves PFS in Chinese patients with ovarian cancer

15 Dec 2020

Can common BP-lowering drugs keep breast cancer in check?

14 Dec 2020 by

Angiotensin receptor blockers, used to treat high blood pressure (BP), appear to confer dose-dependent survival benefits on breast cancer patients when taken either prior to or after diagnosis, a study has found.

Can common BP-lowering drugs keep breast cancer in check?

14 Dec 2020

β-blocker use improves survival in oesophageal cancer patients on chemoradiation

14 Dec 2020

Use of β-blockers results in significant survival benefits in oesophageal cancer patients receiving concurrent chemoradiation, a study has shown.

β-blocker use improves survival in oesophageal cancer patients on chemoradiation

14 Dec 2020

Obesity carries greater risk of colorectal cancer in post- vs premenopausal women

14 Dec 2020

Obesity contributes to a significant increase in the risk of colorectal cancer (CRC) in postmenopausal than in premenopausal women, a study has found.

Obesity carries greater risk of colorectal cancer in post- vs premenopausal women

14 Dec 2020

Antibacterial antibodies suppressed among MM patients

13 Dec 2020

Despite infection being a common complication of multiple myeloma (MM), antibacterial antibodies seem to be present in low levels, a recent study has found.

Antibacterial antibodies suppressed among MM patients

13 Dec 2020

Does age matter in survival of rectal cancer patients?

13 Dec 2020

Age plays a significant role in preoperative treatment, chemotherapy dose, hospitalization rates, and survival among older adults with rectal cancer, confirms a study.

Does age matter in survival of rectal cancer patients?

13 Dec 2020

Is FOLFOX-A a good alternative to FOLFIRINOX for pancreatic cancer?

13 Dec 2020

It appears that adjuvant FOLFOX+nab-paclitaxel (FOLFOX-A) is useful as a multi-agent treatment regimen, indicating its potential as an alternative to FOLFIRINOX, a combination of cancer drugs including folinic acid, fluorouracil, irinotecan, and oxaliplatin, in patients with resected pancreatic ductal adenocarcinoma, suggests a recent study.

Is FOLFOX-A a good alternative to FOLFIRINOX for pancreatic cancer?

13 Dec 2020

News & Updates

Filter by Specialty:

Specialty:

APOLLO: SC daratumumab an effective, convenient option in R/R MM

APOLLO: SC daratumumab an effective, convenient option in R/R MM

Dairy may be protective against colorectal cancer

Dairy may be protective against colorectal cancer

Adjuvant radiotherapy not recommended after radical prostatectomy

Adjuvant radiotherapy not recommended after radical prostatectomy

Niraparib improves PFS in Chinese patients with ovarian cancer

Niraparib improves PFS in Chinese patients with ovarian cancer

Can common BP-lowering drugs keep breast cancer in check?

Can common BP-lowering drugs keep breast cancer in check?

β-blocker use improves survival in oesophageal cancer patients on chemoradiation

β-blocker use improves survival in oesophageal cancer patients on chemoradiation

Obesity carries greater risk of colorectal cancer in post- vs premenopausal women

Obesity carries greater risk of colorectal cancer in post- vs premenopausal women

Antibacterial antibodies suppressed among MM patients

Antibacterial antibodies suppressed among MM patients

Does age matter in survival of rectal cancer patients?

Does age matter in survival of rectal cancer patients?

Is FOLFOX-A a good alternative to FOLFIRINOX for pancreatic cancer?

Is FOLFOX-A a good alternative to FOLFIRINOX for pancreatic cancer?